| Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage | Sarah de Crescenzo | 06/30/20 | San Francisco |
| Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More | Sarah de Crescenzo | 05/29/20 | National |
| Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development | Sarah de Crescenzo | 05/26/20 | San Francisco |
| Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More | Frank Vinluan | 12/13/19 | National |
| Genomics Experts Preview Xconomy’s Aug. 27 Bay Area Biotech Forum | Editors | 08/14/19 | National |
| Turning Genomics Into Better Health on Aug. 27: Early Bird Rate Ends Soon | Ashley Gentile | 08/07/19 | San Francisco |
| Xconomy’s August San Francisco Event to Focus on Genomics and Health | Frank Vinluan | 07/29/19 | San Francisco |
| Gilead Ups Stake in Galapagos With $5B Deal to Jumpstart Its R&D | Ben Fidler | 07/15/19 | San Francisco |
| Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More | Ben Fidler | 04/19/19 | National |
| Insitro Lands Three-Year Deal With Gilead to Find New NASH Drugs | Sarah de Crescenzo | 04/16/19 | National |
| Joining AI Drug Discovery Race, Erasca Adds $22M For Cancer Work | Sarah de Crescenzo | 03/06/19 | San Diego |
